NTUS Insider Transactions
Transaction Date (SEC Report) |
Reporting Name | Relationship | Shrs. Owned | Type | Acq./Disp. | Shrs. Transacted | Price() | Amount() |
---|---|---|---|---|---|---|---|---|
2022-07-21 | LEVINE JOSHUA | director | 0 | D-Return | D | 37,387 | 33.50 | 1,252,464.00 |
2022-07-21 | Heine Lisa Wipperman | director | 0 | D-Return | D | 26,287 | 33.50 | 880,614.00 |
2022-07-21 | Sullivan Thomas Joseph | director, officer: President and CEO | 720,903 | A-Award | A | 648,554 | 0.00 | 0.00 |
2022-07-21 | Sullivan Thomas Joseph | director, officer: President and CEO | 0 | D-Return | D | 720,903 | 33.50 | 24,150,250.00 |
2022-07-21 | Noll Austin Francis III | officer: Executive VP and CCO | 200,509 | A-Award | A | 61,966 | 0.00 | 0.00 |
2022-07-21 | Noll Austin Francis III | officer: Executive VP and CCO | 0 | D-Return | D | 200,509 | 33.50 | 6,717,052.00 |
2022-07-21 | Noll Austin Francis III | officer: Executive VP and CCO | 0 | D-Return | D | 72,534 | 20.68 | 1,500,003.00 |
2022-07-21 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 83,374 | A-Award | A | 35,056 | 0.00 | 0.00 |
2022-07-21 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 0 | D-Return | D | 83,374 | 33.50 | 2,793,029.00 |
2022-07-21 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 0 | D-Return | D | 35,360 | 20.68 | 731,245.00 |
2022-06-15 | LEVINE JOSHUA | director | 37,387 | A-Award | A | 5,075 | 0.00 | 0.00 |
2022-06-15 | Heine Lisa Wipperman | director | 26,287 | A-Award | A | 5,075 | 0.00 | 0.00 |
2022-01-04 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 48,318 | F-InKind | D | 2,796 | 24.02 | 67,160.00 |
2022-01-04 | Noll Austin Francis III | officer: Executive VP and CCO | 140,539 | F-InKind | D | 3,710 | 24.02 | 89,114.00 |
2022-01-03 | Noll Austin Francis III | officer: Executive VP and CCO | 144,249 | A-Award | A | 25,625 | 24.00 | 615,000.00 |
2021-12-31 | Noll Austin Francis III | officer: Executive VP and CCO | 125,130 | A-Award | A | 3,676 | 23.73 | 87,231.00 |
2021-12-31 | Noll Austin Francis III | officer: Executive VP and CCO | 123,528 | F-InKind | D | 1,602 | 23.73 | 38,015.00 |
2022-01-02 | Noll Austin Francis III | officer: Executive VP and CCO | 118,624 | F-InKind | D | 4,904 | 23.73 | 116,372.00 |
2022-01-03 | Sullivan Thomas Joseph | director, officer: President and CEO | 72,349 | A-Award | A | 52,084 | 24.00 | 1,250,016.00 |
2022-01-03 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 51,114 | A-Award | A | 14,084 | 24.00 | 338,016.00 |
2021-12-31 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 42,289 | A-Award | A | 2,363 | 23.73 | 56,074.00 |
2021-12-31 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 41,076 | F-InKind | D | 1,213 | 23.73 | 28,784.00 |
2022-01-02 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 37,030 | F-InKind | D | 4,046 | 23.73 | 96,012.00 |
2021-12-09 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 51,713 | M-Exempt | A | 11,787 | 20.68 | 243,755.00 |
2021-12-09 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 39,926 | S-Sale | D | 11,787 | 23.08 | 272,044.00 |
2021-12-09 | CHUNG DONG CHUNE CHRISTOPHER | officer: Chief Medical Officer | 35,360 | M-Exempt | D | 11,787 | 20.68 | 243,755.00 |
2021-06-17 | Sullivan Thomas Joseph | director | 20,265 | A-Award | A | 5,214 | 28.77 | 150,007.00 |
2021-06-17 | PAUL BARBARA R | director | 29,772 | A-Award | A | 5,214 | 28.77 | 150,007.00 |
2021-06-17 | LEVINE JOSHUA | director | 32,312 | A-Award | A | 5,214 | 28.77 | 150,007.00 |
2021-06-17 | Heine Lisa Wipperman | director | 21,212 | A-Award | A | 5,214 | 28.77 | 150,007.00 |
2021-05-27 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 53,234 | S-Sale | D | 10,467 | 27.10 | 283,656.00 |
2021-05-28 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 52,426 | S-Sale | D | 808 | 26.90 | 21,735.00 |
2021-06-01 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 39,926 | S-Sale | D | 12,500 | 27.55 | 344,375.00 |
2021-05-24 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 73,136 | S-Sale | D | 20,000 | 27.11 | 542,200.00 |
2021-05-25 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 63,701 | S-Sale | D | 9,435 | 27.41 | 258,613.00 |
2021-05-18 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 108,793 | S-Sale | D | 2,904 | 26.90 | 78,118.00 |
2021-05-19 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 102,426 | S-Sale | D | 6,367 | 26.54 | 168,980.00 |
2021-05-20 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 93,136 | S-Sale | D | 9,290 | 27.00 | 250,830.00 |
2021-05-12 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 161,345 | S-Sale | D | 10,108 | 27.47 | 277,667.00 |
2021-05-13 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 133,624 | S-Sale | D | 27,721 | 27.96 | 775,079.00 |
2021-05-14 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 111,697 | S-Sale | D | 21,927 | 28.31 | 620,753.00 |
2021-04-30 | Noll Austin Francis III | officer: Executive VP and CCO | 121,454 | A-Award | A | 489 | 21.72 | 10,621.00 |
2021-04-30 | Kennedy Jonathan | director, officer: President and CEO | 191,810 | A-Award | A | 489 | 21.72 | 10,621.00 |
2021-01-04 | Kennedy Jonathan | director, officer: President and CEO | 200,146 | A-Award | A | 200,146 | 20.61 | 4,125,009.00 |
2021-01-04 | Kennedy Jonathan | director, officer: President and CEO | 191,321 | A-Award | A | 66,716 | 20.61 | 1,375,017.00 |
2020-12-31 | Kennedy Jonathan | director, officer: President and CEO | 139,590 | J-Other | D | 22,695 | 20.04 | 454,808.00 |
2021-01-02 | Kennedy Jonathan | director, officer: President and CEO | 124,605 | F-InKind | D | 14,985 | 20.04 | 300,299.00 |
2021-01-04 | Kennedy Jonathan | director, officer: President and CEO | 66,716 | A-Award | A | 66,716 | 20.61 | 1,375,017.00 |
2021-01-04 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 171,453 | A-Award | A | 21,835 | 20.61 | 450,019.00 |
2021-01-02 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 149,618 | F-InKind | D | 5,263 | 20.04 | 105,471.00 |
2021-01-04 | Noll Austin Francis III | officer: Executive VP and CCO | 120,965 | A-Award | A | 33,965 | 20.61 | 700,019.00 |
2021-01-02 | Noll Austin Francis III | officer: Executive VP and CCO | 87,000 | F-InKind | D | 6,704 | 20.04 | 134,348.00 |
2020-11-13 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 47,147 | A-Award | A | 47,147 | 20.68 | 975,000.00 |
2020-11-13 | Noll Austin Francis III | officer: Executive VP and CCO | 72,534 | A-Award | A | 72,534 | 20.68 | 1,500,003.00 |
2020-10-30 | Kennedy Jonathan | director, officer: President and CEO | 162,285 | A-Award | A | 686 | 15.48 | 10,619.00 |
2020-10-30 | Noll Austin Francis III | officer: Executive VP and CCO | 93,704 | A-Award | A | 686 | 15.48 | 10,619.00 |
2020-08-07 | Heine Lisa Wipperman | director | 15,998 | S-Sale | D | 1,200 | 18.03 | 21,636.00 |
2020-06-19 | Sullivan Thomas Joseph | director | 15,051 | A-Award | A | 7,120 | 21.07 | 150,018.00 |
2020-06-19 | Heine Lisa Wipperman | director | 17,198 | A-Award | A | 7,120 | 21.07 | 150,018.00 |
2020-06-19 | LEVINE JOSHUA | director | 27,098 | A-Award | A | 7,120 | 21.07 | 150,018.00 |
2020-06-19 | PAUL BARBARA R | director | 24,558 | A-Award | A | 7,120 | 21.07 | 150,018.00 |
2020-01-10 | Kennedy Jonathan | director, officer: President and CEO | 161,599 | A-Award | A | 42,101 | 32.66 | 1,375,019.00 |
2020-01-02 | Kennedy Jonathan | director, officer: President and CEO | 122,478 | F-InKind | D | 19,279 | 32.66 | 629,652.00 |
2020-01-04 | Kennedy Jonathan | director, officer: President and CEO | 119,498 | F-InKind | D | 2,980 | 32.59 | 97,118.00 |
2020-01-02 | Noll Austin Francis III | officer: Executive VP and CCO | 93,018 | A-Award | A | 16,075 | 32.66 | 525,010.00 |
2020-01-02 | Noll Austin Francis III | officer: Executive VP and CCO | 78,288 | F-InKind | D | 6,905 | 32.66 | 225,517.00 |
2020-01-04 | Noll Austin Francis III | officer: Executive VP and CCO | 76,943 | F-InKind | D | 1,345 | 32.59 | 43,834.00 |
2020-01-02 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 154,881 | A-Award | A | 10,334 | 32.66 | 337,508.00 |
2020-01-02 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 145,436 | F-InKind | D | 5,462 | 32.66 | 178,389.00 |
2020-01-04 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 144,547 | F-InKind | D | 889 | 32.59 | 28,973.00 |
2019-12-06 | Kennedy Jonathan | director, officer: President and CEO | 148,441 | M-Exempt | A | 7,600 | 22.50 | 171,000.00 |
2019-12-06 | Kennedy Jonathan | director, officer: President and CEO | 141,757 | S-Sale | D | 6,684 | 31.54 | 210,813.00 |
2019-12-06 | Kennedy Jonathan | director, officer: President and CEO | 2,240 | M-Exempt | D | 6,684 | 22.50 | 150,390.00 |
2019-11-05 | Kennedy Jonathan | director, officer: President and CEO | 145,109 | M-Exempt | A | 5,000 | 22.50 | 112,500.00 |
2019-11-04 | Kennedy Jonathan | director, officer: President and CEO | 144,517 | M-Exempt | A | 5,000 | 22.50 | 112,500.00 |
2019-11-05 | Kennedy Jonathan | director, officer: President and CEO | 140,841 | S-Sale | D | 4,268 | 34.32 | 146,478.00 |
2019-11-04 | Kennedy Jonathan | director, officer: President and CEO | 140,109 | S-Sale | D | 4,408 | 33.65 | 148,329.00 |
2019-11-05 | Kennedy Jonathan | director, officer: President and CEO | 1,324 | M-Exempt | D | 4,268 | 22.50 | 96,030.00 |
2019-11-04 | Kennedy Jonathan | director, officer: President and CEO | 592 | M-Exempt | D | 4,408 | 22.50 | 99,180.00 |
2019-10-30 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 164,898 | M-Exempt | A | 14,000 | 22.50 | 315,000.00 |
2019-10-30 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 150,898 | S-Sale | D | 14,000 | 33.57 | 469,980.00 |
2019-10-30 | CHUNG DONG CHUNE CHRISTOPHER | officer: VP of Medical Affairs | 0 | M-Exempt | D | 14,000 | 22.50 | 315,000.00 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.